Title : Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.

Pub. Date : 2015 Oct

PMID : 26096332






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combined simeprevir (SMV) and sofosbuvir (SOF) with or without ribavirin (RBV) results in high sustained virological response (SVR) rates along with minimal adverse events (AEs) in patients with hepatitis C genotype 1 (HCV GT1). Simeprevir beta-1,4-galactosyltransferase 1 Homo sapiens
2 Combined simeprevir (SMV) and sofosbuvir (SOF) with or without ribavirin (RBV) results in high sustained virological response (SVR) rates along with minimal adverse events (AEs) in patients with hepatitis C genotype 1 (HCV GT1). Simeprevir beta-1,4-galactosyltransferase 1 Homo sapiens